Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2004Journal of Antimicrobial ChemotherapyOpen Access

Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case–control study

View Full Paper
Ask AI
Bookmark
Share

Authors

ÉSÉric SennevilleCentre Hospitalier de TourcoingLLL. LegoutUniversité Claude Bernard Lyon 1MVM. ValetteArkema (France)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Senneville et al. (2004) studied this question.

synapsesocial.com/papers/6a7205ae439bab0cabc3bcbchttps://doi.org/10.1093/jac/dkh409
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus aureus with Vancomycin and Rifampin1983 · 114 citations
  2. 2Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open‐Label Trial of Linezolid versus Ampicillin‐Sulbactam/Amoxicillin‐Clavulanate2003 · 312 citations
  3. 3Comparison of Linezolid Activities under Aerobic and Anaerobic Conditions against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus faecium2002 · 15 citations
  4. 4Linezolid‐Induced Pure Red Blood Cell Aplasia2002 · 50 citations
  5. 5Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program2003 · 431 citations